Grace K. Dy

12.5k total citations
213 papers, 4.7k citations indexed

About

Grace K. Dy is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Grace K. Dy has authored 213 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Oncology, 114 papers in Pulmonary and Respiratory Medicine and 75 papers in Molecular Biology. Recurrent topics in Grace K. Dy's work include Lung Cancer Treatments and Mutations (87 papers), Lung Cancer Research Studies (40 papers) and Colorectal Cancer Treatments and Studies (28 papers). Grace K. Dy is often cited by papers focused on Lung Cancer Treatments and Mutations (87 papers), Lung Cancer Research Studies (40 papers) and Colorectal Cancer Treatments and Studies (28 papers). Grace K. Dy collaborates with scholars based in United States, France and Japan. Grace K. Dy's co-authors include Alex A. Adjei, Taimur Sher, Sumithra J. Mandrekar, Smitha Menon, Paul Haluska, Sarah J. Shin, James R. Jett, Steven E. Schild, Julian R. Molina and Lorelei J. Hanson and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Grace K. Dy

205 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Grace K. Dy United States	37	2.3k	2.3k	1.5k	644	429	213	4.7k
Neeltje Steeghs Netherlands	37	2.8k 1.2×	1.7k 0.7×	1.9k 1.3×	857 1.3×	523 1.2×	242	5.4k
Jill Kolesar United States	37	1.8k 0.8×	2.0k 0.9×	936 0.6×	620 1.0×	331 0.8×	192	4.3k
Daniel S.W. Tan Singapore	34	1.8k 0.8×	1.3k 0.6×	1.9k 1.2×	965 1.5×	374 0.9×	159	4.1k
Sarah Danson United Kingdom	31	2.2k 0.9×	1.7k 0.7×	1.1k 0.7×	485 0.8×	227 0.5×	120	4.4k
Robert Justice United States	40	2.5k 1.1×	2.8k 1.2×	1.7k 1.1×	871 1.4×	558 1.3×	61	6.4k
Markus Joerger Switzerland	37	2.2k 1.0×	1.5k 0.6×	1.1k 0.7×	776 1.2×	458 1.1×	215	4.6k
Guido Bocci Italy	42	2.6k 1.1×	2.4k 1.0×	1.0k 0.7×	1.2k 1.9×	400 0.9×	206	5.8k
S. Gail Eckhardt United States	36	2.5k 1.1×	2.6k 1.1×	1.1k 0.7×	1.2k 1.8×	489 1.1×	105	5.3k
Nithya Ramnath United States	33	1.5k 0.7×	1.4k 0.6×	1.7k 1.1×	666 1.0×	334 0.8×	123	4.1k
Miguel A. Villalona‐Calero United States	43	3.2k 1.4×	2.7k 1.2×	2.1k 1.3×	1.1k 1.7×	656 1.5×	187	6.4k

Countries citing papers authored by Grace K. Dy

Since Specialization

Citations

This map shows the geographic impact of Grace K. Dy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grace K. Dy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grace K. Dy more than expected).

Fields of papers citing papers by Grace K. Dy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grace K. Dy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grace K. Dy. The network helps show where Grace K. Dy may publish in the future.

Co-authorship network of co-authors of Grace K. Dy

This figure shows the co-authorship network connecting the top 25 collaborators of Grace K. Dy. A scholar is included among the top collaborators of Grace K. Dy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grace K. Dy. Grace K. Dy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kajihara, Ryutaro, Mark D. Long, Toshifumi Hoki, et al.. (2025). Divergent transcriptional states and kinetics of circulating tumor-infiltrating lymphocyte repertoires with highly homologous T-cell receptor sequences in a patient during immunotherapy. Journal for ImmunoTherapy of Cancer. 13(1). e010092–e010092.

Rittenhouse‐Olson, Kate, et al.. (2024). Exosomal Thomsen–Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses. Cancer Research Communications. 4(8). 1933–1945. 5 indexed citations

Davar, Diwakar, Benedito A. Carneiro, Grace K. Dy, et al.. (2024). Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV–GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumors. Journal for ImmunoTherapy of Cancer. 12(11). e009336–e009336. 9 indexed citations

Nesline, Mary, Rebecca A. Previs, Grace K. Dy, et al.. (2023). PD-L1 Expression by RNA-Sequencing in Non-Small Cell Lung Cancer: Concordance with Immunohistochemistry and Associations with Pembrolizumab Treatment Outcomes. Cancers. 15(19). 4789–4789. 4 indexed citations

Cho, Byoung Chul, Grace K. Dy, Tae Min Kim, et al.. (2023). PP.42 Phase 1 Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced NSCLC. Journal of Thoracic Oncology. 18(3). S25–S25. 1 indexed citations

Seager, R. J., Shuang Gao, Mary Nesline, et al.. (2023). Sex-Specific Effects of Body Composition on Tumor Microenvironment in Non–Small Cell Lung Cancer. Annals of Thoracic Surgery Short Reports. 1(3). 465–468.

Yang, Yunchen, Eric Kannisto, Xie Zeng, et al.. (2023). Simultaneous Detection of Tumor Derived Exosomal Protein–MicroRNA Pairs with an Exo-PROS Biosensor for Cancer Diagnosis. ACS Nano. 17(9). 8108–8122. 59 indexed citations

Abdelfatah, Eihab, Mark D. Long, Ryutaro Kajihara, et al.. (2023). Predictive and Prognostic Implications of Circulating CX3CR1+ CD8+ T Cells in Non–Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy. Cancer Research Communications. 3(3). 510–520. 12 indexed citations

Gomez, Eduardo Cortes, et al.. (2023). Fluctuations in Gut Microbiome Composition During Immune Checkpoint Inhibitor Therapy. World Journal of Oncology. 14(3). 178–187. 7 indexed citations

10.

Skoulidis, Ferdinandos, Martin Schüler, Jennifer Moriatis Wolf, et al.. (2021). MA14.03 Genomic Profiles and Potential Determinants of Response and Resistance in KRAS p.G12C-mutated NSCLC Treated With Sotorasib. Journal of Thoracic Oncology. 16(10). S929–S930. 1 indexed citations

11.

Yamauchi, Takayoshi, Toshifumi Hoki, Takaaki Oba, et al.. (2021). T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors. Nature Communications. 12(1). 1402–1402. 102 indexed citations

12.

Ramalingam, Suresh S., Mark M. Awad, Afshin Dowlati, et al.. (2021). JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer. Cancer. 128(1). 65–74. 58 indexed citations

13.

Yau, Edwin, et al.. (2019). P1.04-10 Identification of Immunotherapy Targets in STK11 Mutant Non-Squamous Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(10). S442–S442.

14.

Liu, Chang, Xie Zeng, Yunchen Yang, et al.. (2018). Sensitive Detection of Exosomal Proteins via a Compact Surface Plasmon Resonance Biosensor for Cancer Diagnosis. ACS Sensors. 3(8). 1471–1479. 163 indexed citations

15.

Weekes, Colin D., Daniel D. Von Hoff, Alex A. Adjei, et al.. (2013). Multicenter Phase I Trial of the Mitogen-Activated Protein Kinase 1/2 Inhibitor BAY 86-9766 in Patients with Advanced Cancer. Clinical Cancer Research. 19(5). 1232–1243. 46 indexed citations

16.

Wee, Wen, Wells A. Messersmith, Grace K. Dy, et al.. (2012). Phase I Study of Rigosertib, an Inhibitor of the Phosphatidylinositol 3-Kinase and Polo-like Kinase 1 Pathways, Combined with Gemcitabine in Patients with Solid Tumors and Pancreatic Cancer. Clinical Cancer Research. 18(7). 2048–2055. 42 indexed citations

17.

LoRusso, Patricia, Antonio Jimeno, Grace K. Dy, et al.. (2011). Pharmacokinetic Dose-Scheduling Study of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors. Clinical Cancer Research. 17(17). 5774–5782. 74 indexed citations

18.

Adjei, Araba A., Oreste E. Salavaggione, Sumithra J. Mandrekar, et al.. (2010). Correlation Between Polymorphisms of the Reduced Folate Carrier Gene (SLC19A1) and Survival After Pemetrexed-Based Therapy in Non-small Cell Lung Cancer: A North Central Cancer Treatment Group-Based Exploratory Study. Journal of Thoracic Oncology. 5(9). 1346–1353. 30 indexed citations

19.

Leil, Tarek A., Chiaki Endo, Araba A. Adjei, et al.. (2007). Identification and Characterization of Genetic Variation in the Folylpolyglutamate Synthase Gene. Cancer Research. 67(18). 8772–8782. 30 indexed citations

20.

Dy, Grace K. & Alex A. Adjei. (2002). Farnesyltransferase Inhibitors in Breast Cancer Therapy. Cancer Investigation. 20(sup2). 30–37. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact